Zoetis tops Q3 earnings forecasts but misses on revenues and trims 2025 sales outlook, sending shares lower on weak U.S.

Zoetis Inc. trades at low valuations despite strong growth and pipeline. Click for my updated look at ZTS stock prospects ...

Zoetis stock slid as Librela sales lagged amid side-effect concerns. Discover analyst insights and what could drive a ...

Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.

The new minimally invasive treatment for IVDD is currently only available in the United Kingdom at the University of ...

Both Cornwell and his dog, Cammie, a boxer-beagle mix, take a daily medication called a selective serotonin reuptake ...